Intravitreal bevacizumab for treatment of choroidal neovascularization associated with osteogenesis imperfecta

A 12-year-old girl, diagnosed of osteogenesis imperfecta, presented with sudden visual loss in the left eye. Investigations revealed an active choroidal neovascular membrane. She underwent treatment with intravitreal Bevacizumab (1.25 mg/0.05 ml). Follow-up at 1 month revealed the development of lac...

Descripción completa

Detalles Bibliográficos
Autores principales: Rishi, Pukhraj, Rishi, Ekta, Venkatraman, Anusha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361825/
https://www.ncbi.nlm.nih.gov/pubmed/22569391
http://dx.doi.org/10.4103/0301-4738.95882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361825/
https://www.ncbi.nlm.nih.gov/pubmed/22569391
http://dx.doi.org/10.4103/0301-4738.95882

Ejemplares similares